IDEAS home Printed from https://ideas.repec.org/a/sae/anname/v468y1983i1p182-195.html
   My bibliography  Save this article

New Horizons in Pharmaceutical Technology

Author

Listed:
  • DUANE M. KIRKING

Abstract

The benefits they provide have contributed toward making drugs the most commonly used treatment modality. Although drugs account for less than 10 percent of all health care expenditures, their total costs can be substantial when one considers the impact of adverse effects as well as the problems resulting from misprescribing and misuse. The 1980s will see the introduction of a large number and variety of new drugs and new ways of delivering drugs to the body. The goals of these developments include increased effectiveness, decreased seriousness and frequency of adverse effects, and less complicated dosing regimes. This new technology raises questions regarding the optimal prescribing, distribution, financing, and use of these new drugs. It is also important to consider what actions should be taken to assure that continued growth in drug technology will occur and that this growth be directed toward the development of drugs that offer significant advantages over existing therapies. Rational policy must consider not only the costs of drugs themselves but also the potential for drugs to reduce the overall cost of health care.

Suggested Citation

  • Duane M. Kirking, 1983. "New Horizons in Pharmaceutical Technology," The ANNALS of the American Academy of Political and Social Science, , vol. 468(1), pages 182-195, July.
  • Handle: RePEc:sae:anname:v:468:y:1983:i:1:p:182-195
    DOI: 10.1177/0002716283468001012
    as

    Download full text from publisher

    File URL: https://journals.sagepub.com/doi/10.1177/0002716283468001012
    Download Restriction: no

    File URL: https://libkey.io/10.1177/0002716283468001012?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:sae:anname:v:468:y:1983:i:1:p:182-195. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: SAGE Publications (email available below). General contact details of provider: .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.